Biotech Values

[DewDiligence]

I suppose the limiting case would be one visit for consultation and genotyping, one visit for prescribing, and a 12 week "end-of-treatment" visit for confirmation of cure…

The confirmation visit is not at the end of treatment, but rather 12 or more weeks after the end of treatment to ensure that there has been no relapse.

how close to this limiting case do you think these regimens might come in practice?

For run-of-the-mill patients, I think three or possibly four physician visits will suffice in most cases.